Library / Laws / 114th Congress / House Bills / H.R. 2101
H.R. 2101
To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited review of drugs and biological products to provide safer or more effective treatment for males or females, to amend the Public Health Service Act to enhance the consideration of sex differences in basic and clinical research, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2015-04-29 | 11.4K | ⠃⠗⠋ |